Evidence map›Paper›PMID 42346716›Full record

ArticleJournal of Intelligence2026

From Incremental Validity to Decision Utility: A Framework for Intelligence Testing in Education.

Liliana Pedraja-Rejas, Carmen Araneda-Guirriman, Emilio Rodríguez-Ponce

Abstract read
In one paragraph

Article in Journal of Intelligence, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Liliana Pedraja-RejasDepartamento de Ingeniería Industrial y de Sistemas, Facultad de Ingeniería, Universidad de Tarapacá, Arica 1000000, Chile.ORCID 0000-0001-7732-4183
Carmen Araneda-GuirrimanDepartamento de Ingeniería Industrial y de Sistemas, Facultad de Ingeniería, Universidad de Tarapacá, Arica 1000000, Chile.
Emilio Rodríguez-PonceInstituto de Alta Investigación, Universidad de Tarapacá, Arica 1000000, Chile.ORCID 0000-0003-4861-002X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intelligence tests predict academic achievement, but their use in educational decision-making remains contested. We develop a decision-analytic framework, centered on a staged decision architecture, to determine when, for whom, and for which educational decisions intelligence testing adds value beyond grades, achievement measures, and contextual evidence. Drawing on psychometric scholarship, a generative account of achievement, and illustrative decision scenarios, we distinguish incremental validity from decision utility. Incremental validity refers to the predictive gain obtained by adding cognitive measures, whereas decision utility refers to the net benefit of using those measures once base rates, capacity constraints, error costs, fairness, and legitimacy are considered. We use the framework to identify conditions in which intelligence testing is expected to be most informative, especially educational transitions, contexts with uneven opportunity, and discrepancy-focused decisions such as underachievement or twice-exceptionality. We also specify minimum conditions for responsible use, including intended use, construct representation, reliability or precision, measurement comparability, predictive bias checks, and monitoring of distributional impact. We conclude that intelligence testing should be used conditionally and sequentially, with achievement and contextual indicators used first and cognitive assessment added only when it is likely to change the decision.

Indexed as

academic achievementdecision utilityeducational placementincremental validityintelligence testingmeasurement comparability

Identifiers

PMID42346716
PMCPMC13302299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.